19 May 2013
Keywords: gsk, dutasteride, bph, cleared, usa, towards, end
Article | 07 January 2002
Towards the end of last year, GlaxoSmithKline was awarded approval inthe USA to market its novel 5-alpha reductase inhibitor dutasteride ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 January 2002
17 May 2013
© 2013 thepharmaletter.com